The possibility that antibody responses in serum, saliva, or breast milk samples to oral vaccines or enteric infections may reflect the intestinal immune response was evaluated in Bangladeshi volunteers orally immunized with a cholera B subunit-whole-cell vaccine (B+WCV) and in patients convalescing from enterotoxin-induced diarrheal disease. Two Secretory immunoglobulin A (IgA) antibodies produced locally in the intestine are important for specific immune protection against cholera, enterotoxigenic Escherichia coli diarrhea, and disease caused by other noninvasive enteric pathogens (10, 13, 17, 25) . Intestinal antibody formation in humans has been monitored by measuring antibody titer increases in fecal specimens, duodenal aspirates, or intestinal lavage fluids (4, 12, 18, 26 Specimens were analyzed from 27 healthy women between 20 and 35 years old and from 20 patients between 20 and 45 years old with moderate to severe diarrhea, 9 of whom had culture-proven cholera infections and 11 of whom had verified enterotoxin-induced E. coli diarrhea. Signed informed consent had been obtained from all participants before their enrollment in the studies.
antitoxin and anti-LPS IgA responses in intestinal fluids after the vaccination of volunteers showed a sensitivity of 70 to 90% and a predictive accuracy of about 80% for the serum analyses reflecting the intestinal immune responses. Furthermore, antitoxin and anti-LPS antibody responses in saliva and breast milk samples seemed to be useful proxy indicators of a gut mucosal response of these antibodies after enterotoxin-induced diarrheal disease showing sensitivity values of 70 to 90% and predictive accuracy values of 70 to 100%.
Secretory immunoglobulin A (IgA) antibodies produced locally in the intestine are important for specific immune protection against cholera, enterotoxigenic Escherichia coli diarrhea, and disease caused by other noninvasive enteric pathogens (10, 13, 17, 25) . Intestinal antibody formation in humans has been monitored by measuring antibody titer increases in fecal specimens, duodenal aspirates, or intestinal lavage fluids (4, 12, 18, 26) . Each of these procedures has limitations, however. Immunoglobulins in fecal specimens are often extensively degraded by intestinal and bacterial enzymes. Duodenal aspirates are difficult to collect and represent only the very upper part of the intestine. The lavage technique is probably the best available method at present to collect human intestinal fluids representative of the entire small intestine. However, the lavage procedure and the subsequent handling of the specimens are rather laborious and time-consuming. Thus, there is a great need for simpler methods of measuring intestinal immune responses in humans and especially for methods that could be used in studies of larger populations, e.g., in relation to a vaccine trial. Determinations of antibodies in various secretions, e.g., milk and saliva, have been suggested as possible proxy measures of the intestinal immune responses to enteral antigens (10, 18, 23 ; L. Â. Hanson and P. Brandtzaeg, in R. T. Stiehm, ed., Immunological Diseases in Infants and Children, in press). Experimental studies in animals have shown that B-cell immunoblasts from intestinal Peyer's patches can migrate not only to their main "homing target tissue," the intestinal lamina propria, but may also be deposited in other mucosal tissues and secretory glands (14, 28) .
In several recent studies we determined the local gut mucosal immune response in Bangladeshi volunteers after immunizations with a new oral cholera vaccine candidate by measuring specific IgA antibody titer increases in intestinal lavage fluid and compared the response with that seen in patients after clinical cholera or diarrhea caused by enterotoxigenic E. coli (19a, 21, 24) . The aim of this study was 20 and 45 years old with moderate to severe diarrhea, 9 of whom had culture-proven cholera infections and 11 of whom had verified enterotoxin-induced E. coli diarrhea. Signed informed consent had been obtained from all participants before their enrollment in the studies.
The healthy volunteers received two or three peroral immunizations with the cholera B subunit alone or in combination with WCV (B+WCV) in the doses and intervals indicated in Table 1 . Before each immunization, 100 to 150 ml of a 0.1 M NaHCO3 solution was given to neutralize gastric acidity, and 5 min later the B subunit was given alone or in the form B + WCV in 100 to 150 ml of the same solution.
Sampling of specimens. Intestinal lavage fluid, sera, saliva, and, when possible, breast milk were collected from volunteers up to 1 day before (day 0) and then 7 to 9 and 25 to 28 days after each immunization; for patients with cholera and enterotoxigenic E. coli disease, specimens were collected 9 and 28 days after the onset of disease. Both the volunteers and the patients were brought to the study ward at the Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh, and the specimens were collected under the supervision of a physician.
The intestinal lavages were performed by letting the volunteers drink an isotonic salt solution until a watery diarrhea ensued, and the liquid stool was then heat inactivated and concentrated as previously described (18, 24, 26) .
Finger stick blood samples (0.1 ml) were taken, diluted 1:10 with physiological saline, and centrifuge, and then the sera were collected. Volunteers were given Parafilm to chew to induce salivation. Saliva (5-ml specimens) was collected, then heated at 560C for 15 min, and centrifuged (23, 24) . Breast milk specimens were collected by manual expression and then centrifuged to remove fat and cells (23, 24) . The intestinal ravages were kept at -70'C or kept lyophilized at room temperature until used, and the other specimens (serum, saliva, and breast milk) were stored at -20°C.
Antibody and immunoglobulin determinations. Antitoxin and antibacterial antibodies of IgA, IgG, and in some instances, IgM classes were determined in specimens collected after immunization with B +WCV and cholera disease by an enzyme-linked immunosorbent assay (ELISA) with cholera toxin and V. cholerae lipopolysaccharide (LPS) as solid-phase antigens (9, 24) . The GM1-ELISA method was used to study the antitoxin IgA and IgG antibody responses to E. coli heat-labile toxin (LT) (22) in patients with enterotoxigenic E. coli infection, while anti-LPS antibodies of different isotypes were assayed in ELISA microtiter plates by using the homologous E. coli LPS of each patient as the solid-phase antigen (19a) . The detailed procedures of these determinations have been described previously (19a, 21, 24) .
The antibody titers were determined as the interpolated dilutions of the test samples giving A405 at 0.4 above the background when the test wells were allowed to react for 100 min with p-nitrophenyl phosphate substrate. These titers were then adjusted in relation to a reference specimen included in each plate to compensate for in-between variations (19a, 24) . The ELISA titer ascribed to each sample was the mean of three to four determinations performed on different days.
Total IgA was measured by the immunobead ELISA technique (19) or by a modified microplate ELISA method (24) with immunobead-or plastic-adsorbed anti-IgA (BioRad Laboratories, Richmond, Calif.) as the catching antibody. Each IgA value represented the mean of two determinations by either method. Specific antibody activities in intestinal lavage fluid were determined by dividing the ELISA IgA titer by the total IgA concentration (micrograms per milliliter) of the sample to compensate for the variation in immunoglobulin content in specimens collected on different days. Since the total IgA concentrations in saliva and breast milk varied very little daily, pre-and postimmunization speçimens were compared without prior adjustment for total IgA.
The measurement error of the ELISA was determined by duplicate testing of pre-and postimmunization specimens (lavage fluid, serum, and saliva) from 24 to 27 individuals, and in each instance the ratio between the levels of maximal antibody activity in samples obtained before and after immunization was estimated. The variation of the logarithmic ratios was calculated by s2 = Ud12n, in which d represents the difference between the logarithmic ratios and n represents the number of individuals tested. Standard deviations of 0.18 for lavage fluid and 0.08 for serum and saliva were obtained.
Antibacterial antibodies in serum were also measured by a vibriocidal assay (15) . Twofold serial dilutions of serum were tested against V. cholerae T19479 (El Tor, Inaba), and the vibriocidal titer was defined as the highest dilution causing complete inhibition of bacterial growth; a fourfold or greater increase in titer after immunization signified seroconversion.
Data analyses. Comparison of the number of significant (19a, 21, 24) . However, further statistical analyses revealed that a 2.3-fold (=102 x 0-18) or greater difference in antibody activity between pre-and postimmunization specimens (days 0 and 7 to 28, respectively) was statistically significant (P -0.05) for lavage fluids and was therefore chosen to signify antibody conversion in the intestine. The corresponding figure for a significant antibody response between pre-and postimmunization samples in serum, saliva, and breast milk was 1.5-fold (.102 x 0.08).
Immunization with B + WCV was as effective as clinical cholera was in inducing local IgA antitoxin as well as IgA antibody responses to V. cholerae LPS in the intestinal fluids of most Bangladeshi volunteers (Tables 2 and 3 ). Antitoxin responses in saliva, breast milk, and serum samples were also observed in many of the vaccinees (Table 2) , while only modest and irregular rises in anti-LPS titers were noted after vaccination. Vibriocidal titer increases in sera were, however, frequently observed after the administration of B+WCV (Table 3) .
Antibody responses after enterotoxin-induced diarrhea. Local antitoxic and antibacterial antibody responses in intestinal lavage fluids were noted in 78 and 89%, respectively, of the patients convalescing from clinical cholera ( Table 4) . Salivary IgA antitoxin as well as rises in anti-LPS titers were induced in 78% of the patients, and all the lactating women responded to both antigens in breast milk samples. Significant antitoxin and anti-LPS IgG titer increases in sera were found in 89 and 56%, respectively, of the cases after disease. Serum vibriocidal titer increases were observed in all patients. In most instances an intestinal immune response was accompanied by a significant rise in antibody titers in saliva, breast milk, and serum samples (Table 4) .
Natural enterotoxigenic E. coli disease resulted in most instances in significant rises in antitoxic (anti-LT) and antibacterial (anti-LPS) IgA titers not only in intestinal fluids but also in other secretions (Table 4) . About 80% of all patients with enterotoxigenic E. coli disease responded with anti-LT and anti-LPS titer increases in intestinal specimens, and about two-thirds of those lactating responded to both antigens in breast milk samples. Salivary anti-LT and anti-LPS antibody responses were noted in 80 and 64%, respectively, of the patients. Serum IgG antibody responses were also frequent and occurred in about two-thirds of the patients during convalescence from enterotoxigenic E. coli disease. The majority of these patients with significant IgA antibody titer increases in intestinal samples also responded with titer increases in the other body fluids after disease ( intestinal fluids were observed in two-thirds of the responders 25 to 28 days after vaccination, and in serum samples the antitoxin titers remained elevated for 95% of the responders by the end of the study. Significant rises in anti-LPS IgA titers in intestinal specimens appeared in more than half of the responders 7 to 9 days after the initial immunization and in all responders after two doses of WCV; for the most part, the titers remained significantly elevated for at least 1 month. Peak vibriocidal titer increases in sera were seen as early as days 7 to 9 for all responders. A significant decrease in vibriocidal titers was found in 60% of the volunteers within 1 month after the initial immunization, and in most cases the titers had returned to preimmunization levels. After clinical cholera and LT-verified E. coli diarrhea, the highest antitoxin and antibacterial titer increases were usually seen on day 9 not only in intestinal fluids but also in serum, saliva, and breast milk samples.
Comparison of antitoxin responses in different body fluids. The numbers of significant antitoxin responses in saliva, breast milk, and serum specimens were compared with responses in intestinal fluids by using four-field table analyses, and the sensitivity and predictive accuracy for reflecting rises in intestinal fluid titers in each extraintestinal fluid were calculated. The specificity of antibody determinations in the different body fluids for reflecting intestinal fluids after a second antigen administration ( Table 6 ). The correlation between magnitudes of antibody responses in intestinal and other body fluids after clinical cholera and enterotoxigenic E. coli disease could not be calculated, since baseline (i.e., day 0) values were lacking.
Comparison of antibacterial responses. Repeated immunization with WCV seemed to be more effective in inducing IgA antibody responses to V. cholerae LPS in intestinal fluid than in saliva, breast milk, and serum samples. The number of anti-LPS responses in extraintestinal body fluids after vaccination was too small to permit a meaningful statistical comparison with the gut mucosal antibody responses. However, WCV induced significant vibriocidal titers in serum samples in most of the volunteers after both one and two doses (Fig. 1) . Those volunteers who did not respond to oral WCV with vibriocidal titer increases generally had high preimmunization levels of serum vibriocidal antibodies. In all cases anti-LPS IgA responses in intestinal fluid were accompanied by either significant vibriocidal titer increases in serum specimens or by high initial levels of vibriocidal antibodies. After single and repeated immunizations with WCV serum, vibriocidal responses were noted without corresponding IgA anti-LPS titer increases in intestinal samples from 20 and 8%, respectively, of the volunteers.
In most instances, clinical cholera and enterotoxigenic E. coli diarrhea evoked antibody responses against the homologous LPS not only in intestinal fluid but also in saliva, breast milk, and serum samples. A comparison of anti-LPS responses in extraintestinal fluids and intestinal lavage fluid gave somewhat higher sensitivity and predictive accuracy values for saliva and breast milk antibody determinations than for the serum analyses. The sensitivity and predictive accuracy of fluid analyses were, respectively, 81 appearance of specific secretory IgA antibodies in breast milk and saliva (1, 7, 14, 23) and also in serum antibodies of various isotypes (5, 21, 22, 25 (25) .
We compared the antibody responses in intestinal fluid with those in serum, saliva, and breast milk samples after oral cholera vaccination and enterotoxin-induced diarrhea.
From the analyses it is clear that none of the extraintestinal body fluids directly reflected the intestinal immune responses after immunization or clinical disease. However, the results suggest that both vibriocidal and IgG antitoxin antibodies in serum samples may still be useful as reasonably accurate indirect measures of the intestinal cholera immune response after oral immunization. In addition the data suggest that after cholera or enterotoxigenic E. coli diarrhea, VOL. 24, 1986 on November 6, 2017 by guest http://jcm.asm.org/ Downloaded from antitoxic and anti-LPS antibodies in saliva and breast milk specimens also seem to usefully reflect the gut mucosal response.
We found that two peroral doses of B+WCV gave rise to antitoxic as well as antibacterial IgA antibody formation in intestinal fluid, which closely resembled the responses induced by cholera disease; the slightly modified cutoff values that were used to signify seroconversion had only minor effects on the number of responders for each type of antibody, compared with previously reported figures (19a, 21, 24, 26) . However, although substantial antibody titer increases in sera were found after both immunization and disease, antibody formation in saliva and breast milk was less frequent after vaccination than after clinical cholera or enterotoxigenic E. coli disease. It is not known whether this discrepancy among responses in nonintestinal secretions was due to the fact that cholera toxin is a potent adjuvant which might have diverted the traffic of antigen-committed cells back to the intestine and away from the secretory glands (8) , or that the dose of B+WCV given was too small compared with cholera disease to induce antibody responses in saliva and breast milk samples. After the immunization of volunteers, salivary IgA antibodies seemed to reflect intestinal immunity to the cholera B subunit better than breast milk IgA antibodies did. The predictive accuracies were similar for the two secretions, but the sensitivities differed. Moreover, a significant correlation between the magnitudes of antitoxin IgA antibody responses in saliva samples and intestinal fluids was found after immunization with the B subunit, whereas no such relation was seen for the responses in breast milk and lavage samples. Still, the sensitivity of either of these determinations was rather low, since only half of those with an intestinal response showed seroconversion in saliva specimens, and only about one third demonstrated this in breast milk samples. After clinical cholera and enterotoxigenic E. coli diarrhea, on the other hand, breast milk IgA antibodies in patients seemed to reflect intestinal immunity to heat-labile enterotoxins at least as well as salivary IgA antibodies did, and since the sensitivity was now better than 70%o (71 to 89%) and the predictive accuracy was also high (71 to 100%), we found either of these determinations useful for reflecting intestinal immunity after disease.
Locally produced antibodies in the intestine are probably of primary importance for protection against cholera, although high concentrations of serum antibodies leaking into the intestine may have some protective effect (3, 10, 20) . Studies in Bangladesh have shown a close inverse relationship between the incidence of cholera and vibriocidal serum antibody titers (5, 16) . The results of this investigation indicate that serum samples are indeed at least as useful as saliva or breast milk specimens in reflecting intestinal immunity after oral administration of B+WCV and clinical disease. With regard to antitoxin antibodies, the sensitivity of serum analyses was always higher than that of saliva or breast milk, and their predictive accuracies were about the same. As to antibacterial antibodies, immunization with B+WCV, with a few exceptions, failed to induce ELISA anti-LPS titer increases in serum but gave rise to vibriocidal titer increases in serum in two-thirds of the volunteers. Clinical cholera, on the other hand, induced both serum vibriocidal and anti-LPS serum antibodies. The better results with the vibriocidal technique may have been due to test detection of anti-LPS antibodies of broader specificity and different isotype than those found by the ELISA anti-LPS assay. Another possibility may have been that the vibriocidal test better discriminated between antibodies of different affinities than the ELISA anti-LPS method did. In most instances, rises in vibriocidal titer seemed to accompany the intestinal responses. Estimation of vibriocidal activity in the various body fluids was not possible owing to the presence of bactericidal substances other than antibodies in these fluids.
We conclude that oral immunization with inactivated cholera immunogens, as contained in B+WCV, can give rise to both local and extraintestinal immune responses in people living in areas where cholera is endemic. Based on the high correlation found between locally produced IgA antibacterial and antitoxin antibodies in intestinal lavage fluid and vibriocidal and IgG antitoxin antibodies in serum samples, we propose that both of these serum antibodies may be useful to screen for intestinal immune responses after oral vaccination, which could be of considerable practical value for the testing of the immunogenicity of cholera vaccine candidates under field conditions. However, since the sensitivities for serum antibody determinations were below 90%, they are not suitable for evaluation of individual responses but may be used for evaluation of immune responses in larger immunization groups. Our results also suggest that antitoxic and anti-LPS antibodies in saliva and breast milk samples may be useful for monitoring gut mucosal response to naturally acquired cholera or enterotoxigenic E. coli diarrhea where they are endemic, but these antibodies were less sensitive than the serum antibodies in reflecting intestinal immunity after artificial immunization.
